48,830
edits
Line 51: | Line 51: | ||
Epidemiology of ''[[C. difficile]]'' pseudomembranous colitis:<ref name=pmid23103666>{{Cite journal | last1 = Jones | first1 = AM. | last2 = Kuijper | first2 = EJ. | last3 = Wilcox | first3 = MH. | title = Clostridium difficile: a European perspective. | journal = J Infect | volume = 66 | issue = 2 | pages = 115-28 | month = Feb | year = 2013 | doi = 10.1016/j.jinf.2012.10.019 | PMID = 23103666 }}</ref> | Epidemiology of ''[[C. difficile]]'' pseudomembranous colitis:<ref name=pmid23103666>{{Cite journal | last1 = Jones | first1 = AM. | last2 = Kuijper | first2 = EJ. | last3 = Wilcox | first3 = MH. | title = Clostridium difficile: a European perspective. | journal = J Infect | volume = 66 | issue = 2 | pages = 115-28 | month = Feb | year = 2013 | doi = 10.1016/j.jinf.2012.10.019 | PMID = 23103666 }}</ref> | ||
*Antibiotics prior to onset (classic history).<ref name=pmid23253319>{{Cite journal | last1 = Bassetti | first1 = M. | last2 = Villa | first2 = G. | last3 = Pecori | first3 = D. | last4 = Arzese | first4 = A. | last5 = Wilcox | first5 = M. | title = Epidemiology, diagnosis and treatment of Clostridium difficile infection. | journal = Expert Rev Anti Infect Ther | volume = 10 | issue = 12 | pages = 1405-23 | month = Dec | year = 2012 | doi = 10.1586/eri.12.135 | PMID = 23253319 }}</ref> | *Antibiotics prior to onset (classic history).<ref name=pmid23253319>{{Cite journal | last1 = Bassetti | first1 = M. | last2 = Villa | first2 = G. | last3 = Pecori | first3 = D. | last4 = Arzese | first4 = A. | last5 = Wilcox | first5 = M. | title = Epidemiology, diagnosis and treatment of Clostridium difficile infection. | journal = Expert Rev Anti Infect Ther | volume = 10 | issue = 12 | pages = 1405-23 | month = Dec | year = 2012 | doi = 10.1586/eri.12.135 | PMID = 23253319 }}</ref> | ||
* | *Typically hospitalized. | ||
* | *Typically older individuals. | ||
==Gross== | ==Gross== |
edits